1. 6 Alpha-methylprednisolone Sodium Hemisuccinate
2. A-methapred
3. Hemisuccinate, Methylprednisolone
4. Methylprednisolone Hemisuccinate Monosodium Salt
5. Methylprednisolone Sodium Hemisuccinate
6. Methylprednisolone Sodium Succinate
7. Methylprednisolone Succinate
8. Sodium Hemisuccinate, Methylprednisolone
9. Sodium Succinate, Methylprednisolone
10. Solu-medrol
11. Solumedrol
12. Succinate, Methylprednisolone
13. Urbason-soluble
14. Urbasonsoluble
1. 2921-57-5
2. Methylprednisolone Succinate
3. Methylprednisolone Hydrogen Succinate
4. Methylprednisolone Hydrogen Hemisuccinate
5. Methylprednisolone Hemisuccinate [usp]
6. 4-[2-[(6s,8s,9s,10r,11s,13s,14s,17r)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic Acid
7. 5gmr90s4kn
8. 6alpha-methylprednisolone Hemisuccinate
9. 6alpha-methylprednisolone 21-hemisuccinate
10. Methylprednisolone Hemisuccinate (usp)
11. Ncgc00185763-01
12. Einecs 220-863-9
13. Unii-5gmr90s4kn
14. Ec 220-863-9
15. Schembl7915
16. 11beta,17,21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-(hydrogen Succinate)
17. Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, (6alpha,11beta)-
18. Methylpredinisolone Hemisuccinate
19. Chembl1201265
20. Dtxsid80183466
21. 6-methylprednisolone Hemisuccinate
22. Chebi:135765
23. Methylprednisolone-sodium-succinate
24. Hy-b1900
25. Zinc3977781
26. Methylprednisolone Succinate (jp17)
27. S6588
28. 6-methylprednisolone-21-hemisuccinate
29. Akos015894899
30. Cs-8183
31. Db14644
32. Ncgc00185763-03
33. As-76484
34. Methylprednisolone Succinate [jan]
35. D05000
36. D97631
37. Methylprednisolone Hemisuccinate [usp-rs]
38. Methylprednisolone Hemisuccinate [who-dd]
39. 921m575
40. A819819
41. Methylprednisolone Hydrogen Succinate [mart.]
42. Methylprednisolone Hemisuccinate [usp Impurity]
43. Q27262132
44. Methylprednisolone Hemisuccinate [usp Monograph]
45. Methylprednisolone Hydrogen Succinate For Performance Test
46. Methylprednisolone Hydrogen Succinate For Peak Identification
47. 11beta,17,21-trihydroxy-6alpha-methyl-3,20-dioxopregna-1,4-dien-21-yl 3-carboxypropionate
48. 11beta,17,21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-succinate
49. 4-(2-((6s,8s,9s,10r,11s,13s,14s,17r)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3h-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)-4-oxobutanoic Acid
50. 4-[2-[(6s,8s,9s,10r,11s,13s,14s,17r)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethoxy]-4-oxo-butanoic Acid
| Molecular Weight | 474.5 g/mol |
|---|---|
| Molecular Formula | C26H34O8 |
| XLogP3 | 2.2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 7 |
| Exact Mass | 474.22536804 g/mol |
| Monoisotopic Mass | 474.22536804 g/mol |
| Topological Polar Surface Area | 138 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 981 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 2 | |
|---|---|
| Drug Name | Methylprednisolone sodium succinate |
| Drug Label | SOLU-MEDROL Sterile Powder is an antiflammatory glucocorticoid, which contains methylprednisolone sodium succinate as the active ingredient. Methylprednisolone sodium succinate, USP, is the sodium succinate ester of methylprednisolone, and it occurs... |
| Active Ingredient | Methylprednisolone sodium succinate |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 2gm base/vial; eq 40mg base/vial; eq 125mg base/vial; eq 500mg base/vial; eq 1gm base/vial |
| Market Status | Prescription |
| Company | Mustafa Nevsat; Fresenius Kabi Usa |
| 2 of 2 | |
|---|---|
| Drug Name | Methylprednisolone sodium succinate |
| Drug Label | SOLU-MEDROL Sterile Powder is an antiflammatory glucocorticoid, which contains methylprednisolone sodium succinate as the active ingredient. Methylprednisolone sodium succinate, USP, is the sodium succinate ester of methylprednisolone, and it occurs... |
| Active Ingredient | Methylprednisolone sodium succinate |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 2gm base/vial; eq 40mg base/vial; eq 125mg base/vial; eq 500mg base/vial; eq 1gm base/vial |
| Market Status | Prescription |
| Company | Mustafa Nevsat; Fresenius Kabi Usa |
Methylprednisolone sodium succinate (the sodium salt of methylprednisolone hemisuccinate) has the same metabolic and anti-inflammatory actions as methylprednisolone. When given parenterally and in equimolar quantities, the two compounds are equivalent in biologic activity.
Antineoplastic Agents, Hormonal
Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
Neuroprotective Agents
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)
Glucocorticoids
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)
LOOKING FOR A SUPPLIER?
